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froBACKGROUND Although emotional stress is associated with ischemic heart disease (IHD) and related clinical
events, sex-speciﬁc differences in the psychobiological response to mental stress have not been clearly identiﬁed.
OBJECTIVES We aimed to study the differential psychological and cardiovascular responses to mental stress
between male and female patients with stable IHD.
METHODS Patients with stable IHD enrolled in the REMIT (Responses of Mental Stress–Induced Myocardial Ischemia
to Escitalopram) study underwent psychometric assessments, transthoracic echocardiography, and platelet aggregation
studies at baseline and after 3 mental stress tasks. Mental stress–induced myocardial ischemia (MSIMI) was deﬁned
as the development or worsening of regional wall motion abnormality, reduction of left ventricular ejection fraction
(LVEF) $8% by transthoracic echocardiography, and/or ischemic ST-segment change on electrocardiogram during
1 or more of the 3 mental stress tasks.
RESULTS In the 310 participants with known IHD (18% women, 82% men), most baseline characteristics were similar
between women and men (including heart rate, blood pressure, and LVEF), although women were more likely to be
nonwhite, living alone (p < 0.001), and unmarried (p < 0.001); they also had higher baseline depression and anxiety
(p < 0.05). At rest, women had heightened platelet aggregation responses to serotonin (p ¼ 0.007) and epinephrine
(p ¼ 0.004) compared with men. Following mental stress, women had more MSIMI (57% vs. 41%; p < 0.04), expressed
more negative (p ¼ 0.02) and less positive emotion (p < 0.001), and demonstrated higher collagen-stimulated platelet
aggregation responses (p ¼ 0.04) than men. Men were more likely than women to show changes in traditional physi-
ological measures, such as blood pressure (p < 0.05) and double product.
CONCLUSIONS In this exploratory analysis, we identiﬁed clear, measurable, and differential responses to mental
stress in women and men. Further studies should test the association of sex differences in cardiovascular and
platelet reactivity in response to mental stress and long-term outcomes. (Responses of Myocardial Ischemia to
Escitalopram Treatment [REMIT]; NCT00574847) (J Am Coll Cardiol 2014;64:1669–78) © 2014 by the American
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1670D espite therapeutic advances andgreater awareness of the risk ofcardiovascular disease (CVD) in
women, outcomes and prognoses for women
with CVD remain worse than those for men
(1). This disparity suggests that sex-related
differences in disease presentation, mecha-
nisms, risk factors, and treatment may affect
prognosis (2). Although some researchers
have recently focused on characterizing the
sex-speciﬁc inﬂuence of traditional coronary
disease risk factors, these variables failed to
completely account for the widely disparate
presentations and CVD outcomes between
men and women (3,4).SEE PAGE 1679The association of mental stress and CVD
prognosis is well established (5), and mental
stress is now gaining wide recognition as
a potentially modiﬁable nontraditional CVDrisk factor (6). Sex-speciﬁc differences in the psy-
chobiological response to mental stress have not been
clearly identiﬁed (7) and may provide valuable clues
towards understanding the differential CVD risk in
men and women. Conﬂicting data exist regarding sex-
speciﬁc hemodynamic responses to stress, but con-
clusions are limited by small sample sizes (8–10).
We explored sex differences in response to mental
stress across multiple important domains in CVD
pathophysiology and prognosis (cardiovascular reac-
tivity [11], platelet aggregation [12–15], and cardio-
vascular ischemic responses). We conducted this
study in patients with clinically stable ischemic heart
disease (IHD) who underwent baseline testing in the
REMIT (Responses of Mental Stress Induced Myocar-
dial Ischemia to Escitalopram Treatment) trial (16–18).d research funding from Boston Scientiﬁc–Duke University
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The study cohort examined for this analysis comprised
patients who underwent baseline stress testing as a
screening procedure for mental stress–induced
ischemia (MSIMI) to allow for randomization in the
REMIT trial. The REMIT trial (NCT00574847) study
design (18) and primary results (17) were previously
described. In brief, the REMIT study was a double-
blind clinical trial that randomized subjects with sta-
ble coronary disease and MSIMI to either escitalopram
treatment or placebo. Patients were invited to partici-
pate in screening stress-testing procedures if they had
clinically stable IHD deﬁned as the absence of a recent
(<3 months) myocardial infarction, coronary artery
bypass graft surgery (CABG), or any other revasculari-
zation procedures (e.g., percutaneous transluminal
coronary angioplasty with or without stenting), unsta-
ble angina, and a plan for revascularization procedures.
Patients were excluded if they had other signiﬁcant
medical comorbidities (i.e., cardiac, pulmonary, meta-
bolic, renal, hepatic disease, or malignancy) or psychi-
atric diagnoses (i.e., bipolar spectrum mood disorders,
psychotic disorders, current substance abuse/depen-
dence or history within 6 months, and active suicidal
ideation) that could interfere with participation in the
trial intervention. Patients were also excluded if
they had severe psychiatric symptoms, were preg-
nant, or were using antidepressants, including selec-
tive serotonin reuptake inhibitors. The protocol was
reviewed and approved by the Duke University Health
System Institutional Review Board. All participants
provided written, voluntary informed consent before
participating in any assessment.
MENTAL STRESS AND EXERCISE TESTING. Study
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1671psychometric testing on day 1, and mental and exer-
cise stress testing protocols on day 2. Stress testing
was conducted between 8 AM and 11 AM at the Duke
Cardiac Diagnostic Unit. We chose to withhold only
beta-blockers before stress testing. Other anti-
angina medications (e.g., calcium-channel blockers,
angiotensin-converting enzyme inhibitors, nitrates)
were continued per the patient’s home routine
through the stress testing. Following a 20-min rest
period, participants underwent 3 mental stress tasks
in a ﬁxed sequence: mental arithmetic; mirror trace;
and anger recall (18). Each stress test was followed by
a 6-min rest period to allow any changes to return to
baseline. Patients completed the mental stress pro-
tocol while in a left lateral position to allow for
echocardiography, which was conducted during the
ﬁnal 3 min of each rest period, as well as during each
mental stress task. After the mental stress testing,
patients completed a treadmill exercise test using the
standard Bruce protocol (19). The exercise testing
was terminated according to standard guidelines.
Transthoracic echocardiography was conducted
immediately following the cessation of the exercise.
Because studies were read following completion of all
stress testing procedures, all patients underwent
testing in sequence regardless of the presence or
absence of MSIMI.
CARDIOVASCULAR REACTIVITY TO STRESS. Blood
pressure (BP) was measured and an electrocardio-
gram was recorded at 1-min intervals during each
resting period, mental stress testing period, and
during the exercise stress test. Heart rate (HR) was
determined from the electrocardiogram, and hemo-
dynamic responses (i.e., changes in systolic and dia-
stolic BP, HR, and rate pressure product) were
obtained by subtracting the mean level of recorded
values during each mental task and exercise from the
baseline resting period. The BP and HR difference
between rest and each stress test was considered the
cardiovascular reactivity to stress test.
ASSESSMENT OF MYOCARDIAL ISCHEMIA. Trans-
thoracic echocardiography (20) and electrocardiog-
raphy were used to assess for the presence of
ischemia. Images (parasternal long-axis and short-
axis views, and apical 4-chamber and 2-chamber
views) were acquired using a 3-MHz transducer
while in the harmonic imaging mode of the Philips
iE33 system (Philips Ultrasound, Bothell, Washing-
ton). The American Society of Echocardiography
16-segment model was used to assess left ventricular
wall motion (21). Segmental wall motion was graded
and scored as follows: 1 ¼ normal or hyperdynamic;
2 ¼ hypokinetic; 3 ¼ akinetic; 4 ¼ dyskinetic; or 5 ¼aneurysmal wall motion. A wall motion score index
was calculated as the sum of the segmental wall
motion scores divided by the total number of the
scored segments. Separate scores were calculated for
the wall motion data collected at rest, during each of
the 3 mental stress tests, and during the exercise
stress test. The Kappa value for the intraobserver
variability and interobserver variability of wall mo-
tion analysis in this study ranged between 0.80 and
0.87. Left ventricular ejection fraction (LVEF) was
calculated using the biplane Simpson’s method (21).
Biplane LVEF was calculated by a single reader
and repeated in 15 random subjects by another
experienced reader with no systematic difference
(bias 1.7; p ¼ 0.6646) and an intraclass coefﬁcient
of correlation of 0.90 (95% limits of agreement 0.74
to 0.97).
DEFINITION OF STRESS-INDUCED MYOCARDIAL
ISCHEMIA. MSIMI was deﬁned as the development or
a worsening of any wall motion abnormality, reduc-
tion of LVEF $8% by transthoracic echocardiography,
and/or ischemic ST-segment change on electrocar-
diogram occurring during 1 or more of the 3 mental
stress tasks, as compared with rest. Exercise stress–
induced myocardial ischemia was deﬁned as the
presence of any or all of the aforementioned criteria
in response to exercise stress testing.
PSYCHOLOGICAL MEASUREMENTS. The Beck De-
pression Inventory II (BDI-TOT) and the Center for
Epidemiologic Studies Depression (CESD) scales were
used to assess the severity of depressive symptoms.
The BDI-TOT (22) is commonly used to screen for
depressive symptoms in cardiac populations and is
predictive of cardiovascular outcomes (23). The 21
items of the BDI-TOT span emotional, behavioral,
and somatic symptoms.
The CESD (24) is a 20-item questionnaire in which
patients report on the frequency of depressive
symptoms experienced in the past 2 weeks using a 4-
point Likert scale. This assessment was chosen
because it was previously used to test the association
of depression and MSIMI (25). In addition to the BDI-
TOT and the CESD scales, patients were also admin-
istered a series of scales to assess levels of hostility,
anxiety, and perceived social stress. Hostility was
assessed by a 27-item abbreviated version of the
Cook-Medley Hostility Scale (26,27) that contained
subsets of items identiﬁed in a previous study
(27) as reﬂecting cognitive (i.e., cynicism), affective
(i.e., hostile affect), and behavioral (i.e., aggressive
responding) manifestations of hostility. Anxiety was
assessed using the 40-item Spielberger Anxiety Scale
(28), which contains two 20-item subscales measuring
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1672state and trait manifestations of anxiety. Level of
stress was measured via the 10-item Perceived Stress
Scale (29), which measures the degree to which situ-
ations in one’s life are judged as stressful. These
particular scales were selected for use because they
measure psychometric constructs that were associ-
ated with the development and prognosis of IHD in
prior studies (30).
ASSESSMENT OF PLATELET REACTIVITY. Blood
samples were collected at rest and at the end of
mental stress testing in tubes containing 3.8% so-
dium citrate solution (9:1) for platelet aggregation
studies.
Standard methods employed in our laboratory
were used to assess platelet aggregation (31). Brieﬂy,
we separated platelet-rich plasma by centrifugation
for 15 min at 135 g and adjusted it to 250,000 plate-
lets/ml with autologous platelet-poor plasma for use
in a Chronolog 4-channel platelet aggregometer
(Chronolog, Havertown, Pennsylvania). Platelet-poor
plasma displayed 100% optical transmittance. Be-
cause serotonergic and adrenergic stimuli, as well as
collagen and adenosine diphosphate (ADP), affect
platelet activity in vivo, an assessment of the bio-
logical response to multiple stimuli is likely to iden-
tify physiological effects that have implications for
the pathogenesis of thrombosis in stress (31). Thus,
we tested platelet aggregation responses to different
agonists. Epinephrine, ADP, and collagen were
obtained from Chronolog. Serotonin was obtained
from Sigma-Aldrich (St. Louis, Missouri). We evalu-
ated platelet aggregation triggered by epinephrine
10 mmol/l, serotonin 10 mg/ml, collagen 10 mg/ml, and
ADP 5 mmol/l, with each agonist combined with se-
rotonin 10 mg/ml, as well as serotonin 10 mg/ml alone.
The same qualiﬁed technician performed all platelet
aggregation studies using a single instrument and an
identical lot of agonists. Platelet aggregation was
recorded and results reported in terms of the area
under the curve, which was derived by % platelet
aggregation  time in minutes (31).
STATISTICAL ANALYSIS. Baseline characteristics
were described using means and 95% conﬁdence
intervals for continuous variables and percentages
for categorical variables.
Differences between men and women at baseline
and their response to stress were studied in 4 do-
mains: 1) psychosocial stress; 2) cardiovascular reac-
tivity; 3) MSIMI; and 4) platelet aggregation. Analysis
of variance was used to compare continuous variables
between male and female patients. Analyses in which
stress-induced changes in variables (i.e., systolic and
diastolic BP, HR, platelet aggregation, and measuresof state affect) were used as dependent variables
included the appropriate pre-stress (i.e., baseline)
value as a covariate. To increase the reliability of the
measurements obtained during each mental stress
test (i.e., systolic BP/diastolic BP/HR and state affect)
and reduce the number of statistical tests, we aver-
aged the 3 mental stress measurements. The chi-
square test was used to test associations between
categorical variables (i.e., sex and MSIMI). We also
conducted analyses to see whether background fac-
tors, such as race, history of CABG, clopidogrel use
(platelet aggregation analysis only), and severity of
depressive symptoms, might alter the signiﬁcance of
our ﬁndings. The ﬁrst set of analyses controlled for
race, history of CABG, and clopidogrel use (platelet
aggregation analysis only). This was followed by a
second set of analyses that added the BDI score as
an additional covariate. Analyses involving a contin-
uous criterion variable (e.g., blood pressure changes)
used analysis of covariance, and analyses involving
dichotomous criterion variables (i.e., MSIMI) used
logistic regression.
To examine the interrelationships between MSIMI
and stress reactivity measures in men and women, we
used Pearson correlation coefﬁcients to estimate the
bivariate relations between continuous variables.
Logistic regression models were used to test the
relationship between continuous variables and a
dichotomous MSIMI variable. The stress reactivity
variables were adjusted for pre-stress values before
analysis.
Statistical signiﬁcance was deﬁned at an alpha
level of 0.05. All statistical tests were 2-sided. All
statistical calculations were carried out using SAS
version 9.3 (SAS Institute, Cary, North Carolina).
RESULTS
DISTRIBUTION OF BASELINE CHARACTERISTICS. Of
the 310 study participants with stable coronary dis-
ease who completed baseline testing, 56 (18%) were
women. Although most clinical risk factors were
similar between men and women (including HR,
systolic and diastolic BP, and LVEF), women were
more likely to be nonwhite, living alone, and not
married (all p < 0.001) (Table 1). Most study subjects
were on a standard cardiac regimen with aspirin,
beta-blocker, and statin, though a higher proportion
of men reported being on a statin (94% vs. 85%;
p ¼ 0.03) and more women reported using an
antiplatelet agent other than aspirin (57% vs. 40%;
p ¼ 0.02). There were no signiﬁcant differences in
the use of aspirin, beta-blockers, or calcium-channel
blockers.
TABLE 1 Clinical Characteristics
Females
(n ¼ 54)
Males
(n ¼ 256) p Value
Age, yrs 62.8  11.7 63.5  10.3 0.65
Race, % nonwhite 37.0 14.8 <0.001
Body mass index (kg/m2) 28.9  4.9 29.0  4.8 0.85
Living arrangement, alone 35.2 11.7 <0.001
Marital status, not married 63.0 18.0 <0.001
Smoking 0.13
Current 22.2 12.1
Past 46.3 56.3
Never 31.5 31.6
ACE inhibitors 52.8 66.4 0.06
History of CABG 27.8 46.9 0.01
History of PCI 74.1 60.2 0.06
History of diabetes 33.3 27.3 0.38
History of hypertension 75.9 80.9 0.41
History of hyperlipidemia 88.9 95.3 0.07
History of myocardial infarction 0.72
Yes 46.3 44.14
No 51.9 55.1
NS 1.9 0.8
NYHA functional class 0.79
I 88.9 92.1
II 9.3 5.9
III 1.9 2.0
Values are mean  SD or %.
ACE ¼ angiotensin-converting enzyme; CABG ¼ coronary artery bypass graft
surgery; PCI ¼ percutaneous coronary intervention; NYHA ¼ New York Heart
Association.
TABLE 2 Baseline Psychometric, Platelet Aggregation, and
Cardiovascular Hemodynamics
Baseline Psychometric Parameters
Females
(n ¼ 52)
Males
(n ¼ 250) p Value
History of depression 31.48 10.16 <0.001
Baseline sadness 13.6 (7.7–19.5) 6.7 (4.8–8.6) 0.007
Baseline tension 22.7 (15.8–29.6) 15.4 (12.9–17.9) 0.02
Baseline frustration* 15.6 (7.8–23.5) 7.2 (5.3–9.2) 0.18
Baseline calm 74.8 (67.8–81.9) 85.5 (83.1–88.0) <0.001
Baseline in-control 77.4 (70.1–84.6) 82.1 (79.1–85.0) 0.2
Cook-Medley Hostility score 9.6 (8.2–11.0) 10.4 (9.8–11.0) 0.3
State anxiety 31.4 (28.9–34.0) 28.3 (27.2–29.3) 0.02
Trait anxiety 38.6 (35.4–41.9) 33.0 (31.8–34.2) <0.001
Perceived stress 26.6 (24.6–28.5) 22.1 (21.3–23.0) <0.001
BDI II 10.9 (8.6–13.1) 7.9 (7.1–8.7) 0.004
CESD score 33.7 (31.1–36.6) 29.4 (28.4–30.4) <0.001
Resting Platelet Aggregation: Area Under the Curve
Females
(n ¼ 38)
Males
(n ¼ 238) p Value
Epinephrine 10 mmol/l 191.3 (149.8–232.8) 137.9 (125.1–150.8) 0.004
Collagen 10 mmol/l 292.8 (260.0–325.6) 273.1 (260.3–285.9) 0.26
ADP 5 mmol/l 239.6 (199.7–279.5) 248.9 (234.6–263.3) 0.64
5HT 10 mg/ml þ
epinephrine 10 mmol/l
264.6 (232.7–296.5) 241.5 (230.2–252.9) 0.14
5HT 10 mg/ml þ collagen
2 mg/ml
253 (226.9–279.2) 238.7 (226.8–250.7) 0.37
5HT 10 mg/ml þ ADP 1 mmol/l 229.7 (192.3–267.2) 216.2 (202.9–229.5) 0.46
5HT 10 mg/ml 11.5 (2.8–20.3) 4.5 (2.3–6.0) 0.007
Baseline Cardiovascular Hemodynamics
Females
(n ¼ 49)
Males
(n ¼ 242) p Value
Baseline resting SBP 128 (122.4–132.9) 127 (124.3–128.9) 0.73
Baseline resting DBP 71 (68.0–74.0) 73 (71.6–74.6) 0.24
Baseline resting HR 70 (66.7–73.3) 68 (66.2–68.9) 0.14
Baseline resting HR  SBP 8,894 (8,313.5–9,473.5) 8,563 (8,323.2–8,801.9) 0.27
Values are % or mean (95% conﬁdence interval). *A nonparametric method of comparison was used.
ADP ¼ adenosine diphosphate; BDI ¼ Beck Depression Inventory; CESD ¼ Center for Epidemiologic Studies
Depression Scale; DBP ¼ diastolic blood pressure; HR ¼ heart rate; SBP ¼ systolic blood pressure; 5HT ¼
serotonin.
TABLE 3 MSIMI and ESIMI
Females
(n ¼ 53)
Males
(n ¼ 254) p Value
Baseline LVEF 58.7 (55.6 to 61.8) 56.3 (55.0 to 57.6) 0.14
LVEF change in MS 1.36 (2.62 to 0.11) 0.32 (0.94 to 0.30) 0.16
WMSI change in MS 0.06 (0.03 to 0.08) 0.04 (0.03 to 0.06) 0.40
MSIMI, % 56.6 40.9 0.037
ESIMI, % 39.2 32.2 0.34
Values are mean (95% conﬁdence interval).
ESIMI ¼ exercise stress–induced myocardial ischemia; LVEF ¼ left ventricular ejection fraction;
MS ¼ mental stress; MSIMI ¼ mental stress–induced myocardial ischemia; WMSI ¼ wall motion
score index.
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1673Women had a higher prevalence of a history of
depression, and scored higher on scale descriptors of
sadness, tension, perceived stress, and state and trait
anxiety compared with men (p < 0.05). By contrast,
men described feeling calmer than women at rest
(p < 0.05) (Table 2).
A comparison of resting platelet aggregation mea-
sures between men and women revealed nonsigniﬁ-
cant differences in platelet aggregation response to
collagen 10 mg/ml, ADP 5 mmol/l, serotonin (5HT) 10
mg/ml þ epinephrine 10 mm, 5HT 10 mg/ml þ collagen 2
mg/ml, and 5HT 10 mm þ ADP 1mmol/l (Table 2), likely a
result of antiplatelet therapy. However, women had a
higher resting platelet aggregation response to 5HT
(p ¼ 0.007) and epinephrine (p ¼ 0.004). As shown in
Table 2, there were no signiﬁcant differences in
resting HR, systolic and diastolic BP, or double
product between men and women.
CARDIOVASCULAR AND PSYCHOBIOLOGICAL
RESPONSES TO MENTAL STRESS. Following mental
stress, more women had MSIMI (57% vs. 41%;
p < 0.04) than men, but there were no signiﬁcant sex
differences in the rate of exercise stress–induced
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Changes in affect in response to mental stress in men and women.
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FIGURE 2 Sex Differences in Platelet Aggregation Changes in Response
to Mental Stress
Differences among men and women in platelet aggregation changes stimulated by various
agonists in response to mental stress. ADP ¼ adenosine diphosphate; AUC ¼ area under
the curve; Epi ¼ epinephrine; 5HT ¼ serotonin.
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1674myocardial ischemia (Table 3). Women expressed
more negative emotion (p ¼ 0.02) and less positive
emotion (p < 0.01) (Figure 1), and demonstrated a
higher platelet aggregation response to epinephrine,
ADP, and collagen (p ¼ 0.04) (Figure 2), whereas men
showed a greater increase in traditional physiological
measures such as BP and double product (p < 0.05)
(Table 4).
Controlling for race, history of CABG (odds ratio
[OR]: 1.87, 95% conﬁdence interval [CI]: 1.01 to
3.48), and clopidogrel use (platelet aggregation
analysis only) had minimal impact on the association
between sex and stress-induced changes (all p
values <0.05). However, additional control for BDI
depression scores attenuated the sex effect for
MSIMI (OR: 1.68, 95% CI: 0.90 to 3.15; p ¼ 0.11),
stress-induced change in negative affect (p ¼ 0.14),
and to a lesser extent, stress-induced change in
systolic BP (p ¼ 0.056).
INTERRELATIONSHIP OF STRESS REACTIVITY
MEASURES IN MEN AND WOMEN. We also examined
interrelationships of the stress-reactivity measures
that had previously shown statistically signiﬁcant
sex-related differences between men and women
(i.e., systolic and diastolic BP, positive and negative
affect, collagen-stimulated platelet aggregation, and
MSIMI). These relationships were examined sepa-
rately among men and women.
Among women, modest correlations were noted
between stress-induced changes in negative and
positive affect (r ¼ 0.6; p < 0.001), changes in
systolic and diastolic BP (r ¼ 0.5; p < 0.001). In
addition, statistically nonsigniﬁcant trends were
seen in the relationship between changes in
collagen-stimulated stress-induced platelet aggrega-
tion and MSIMI (r ¼ 0.29; p ¼ 0.08), platelet aggre-
gation and negative affect (r ¼ 0.29; p ¼ 0.09), and
platelet aggregation and positive affect (r ¼ 0.3;
p ¼ 0.07). All other correlations among reactivity
indexes were nonsigniﬁcant.
Among men, signiﬁcant relationships were ob-
served between negative and positive affect (r ¼ 0.7;
p < 0.001), and systolic and diastolic BP (r ¼ 0.6;
p < 0.001). In addition, nonsigniﬁcant trends were
noted in the relationship between diastolic BP and
positive affect (r ¼0.2; p ¼ 0.06), and systolic BP and
negative affect (r ¼ 0.11; p ¼ 0.09). There were no
signiﬁcant correlations between affect changes and
MSIMI or collagen-stimulated stress-induced platelet
aggregation in men.
Logistic regression failed to show any signiﬁcant
associations between any of the continuous stress-
reactivity measures and MSIMI.
TABLE 4 Mental Stress–Induced Changes Controlling for Baseline Values
Mental Stress–Induced Affect Change (Controlling for Resting Affect)*
Females
(n ¼ 52)
Males
(n ¼ 250) p Value
Change sadness 13.0 (7.9 to 18.0) 8.3 (6.0 to 10.6) 0.10
Change tension 34.7 (28.7 to 40.8) 25.3 (22.5 to 28.0) 0.005
Change frustration 50.6 (44.3 to 56.95) 42.6 (39.7 to 45.4) 0.02
Change calm 37.1 (43.6 to 30.7) 26.0 (28.9 to 23.1) 0.002
Change in control 39.1 (45.0 to 33.2) 27.4 (30.1 to 24.7) <0.001
Change in negative affect 32.2 (27.3 to 37.1) 25.5 (23.3 to 27.7) 0.016
Change in positive affect 37.9 (43.6 to 32.3) 26.7 (29.3 to 24.2) <0.001
Mental Stress–Induced Platelet Aggregation Changes:
Area Under the Curve (Controlling for Resting Platelet Aggregation)
Females
(n ¼ 38)
Males
(n ¼ 238) p Value
Epinephrine 10 mmol/l 18.2 (2.3 to 38.6) 7.2 (0.95 to 15.2) 0.33
Collagen 10 mg/ml 23.7 (3.3 to 44.1) 0.5 (7.7 to 8.6) 0.039
ADP 5 mmol/l 3.9 (14.9 to 22.8) 2.2 (5.4 to 9.7) 0.87
5HT 10 mg/ml þ
epinephrine 10 mmol/l
17.6 (2.8 to 37.98) 0.7 (8.9 to 7.4) 0.10
5HT 10 mg/ml þ
collagen 2 ug/ml
31.4 (52.4 to 10.4) 35.6 (44.0 to 27.24) 0.72
5HT 10 mg/ml þ
ADP 1 mmol/l
5.0 (23.9 to 13.9) 6.5 (14.0 to 1.1) 0.89
5HT 10 mg/ml 0.8 (7.54 to 9.07) 2.6 (0.69 to 5.88) 0.69
Mental Stress–Induced Hemodynamic Changes (Controlling for Resting Values)
Females
(n ¼ 49)
Males
(n ¼ 242) p Value
SBP change 22 (18 to 25) 26 (25 to 28) 0.02
DBP change 11 (9 to 13) 15 (13 to 16) 0.01
HR change 9 (7 to 12) 9 (8 to 10) 0.99
HR  BP change 2,882 (2,325 to 3,439) 3,257 (3,008 to 3,506) 0.23
Values are least-squared mean (95% conﬁdence interval [CI]). *Values are mean (95% CI).
BP ¼ blood pressure; other abbreviations as in Table 2.
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1675MEDIATORS OF THE RELATIONSHIP OF SEX AND
MSIMI. We next sought to examine whether the
relationship between sex and MSIMI might be
accounted for by sex-related differences in other
reactivity variables. First, we ﬁt a logistic regression
model with the sex variable predicting MSIMI.
The association between sex and MSIMI was signiﬁ-
cant (OR: 1.9; 95% CI: 1.02 to 3.57; p ¼ 0.043) and
remained signiﬁcant after separately controlling for
mental stress–induced changes in systolic BP (OR:
1.96, 95% CI: 1.04 to 3.7; p ¼ 0.04), diastolic BP (OR:
1.96, 95% CI: 1.04 to 3.7; p ¼ 0.03), positive affect
(OR: 2.0, 95% CI: 1.08 to 3.8; p ¼ 0.03), negative
affect (OR: 2.08, 95% CI: 1.1 to 3.9; p ¼ 0.02),
collagen-stimulated mental stress–induced platelet
aggregation (OR: 2.05, 95% CI: 1.02 to 4.15; p ¼
0.045), and resting epinephrine-stimulated platelet
aggregation (OR: 2.2, 95% CI: 1.08 to 4.48; p ¼ 0.03).
DISCUSSION
Our study is novel in its exploration of mental stress–
related sex-speciﬁc differences across multiple,
mechanistically important cardiovascular domains
(Central Illustration). We report: 1) that there are clear,
measurable differences between men and women
across multiple areas, including psychological, car-
diovascular, and biological response to mental stress;
and 2) that compared with men, women expressed
more negative emotion, and had a greater rate of
MSIMI and collagen-stimulated platelet reactivity to
mental stress; conversely, men exhibited greater
cardiovascular reactivity following mental stress. Our
ﬁndings, although exploratory and hypothesis-
generating, carry implications for future research in
this area.
In the last few decades, the recognition of sex dif-
ferences in CVD has evolved with regard to presen-
tation, cardiovascular disease mechanisms, and
outcomes (2,32). Although recent reports document
decreases in CVD mortality for women, it is important
to emphasize that the number of cardiovascular
deaths for women has exceeded men for the last 20
years (33–35). “Paradoxical sex differences” have
been noted in which, compared with men, women
have less obstructive coronary disease and normal left
ventricular function, but higher rates of angina and
death (32,35–38). Microvascular and endothelial
dysfunction has been postulated to play a signiﬁcant
role in presentation and pathogenesis of IHD in
women, where the inﬂuence of mental stress has been
previously examined and proven to be important (39).
Our study builds upon prior work by Martin
and colleagues (39), who demonstrated reducedcardiovascular reactivity and heightened endothelial
dysfunction in response to mental stress in women
without IHD; we examined MSIMI responses in men
and women with known, stable IHD. We report a
signiﬁcantly higher prevalence of MSIMI among
women compared with men. A previous study by
York et al. (40), which examined a comparable
cohort of females, failed to show a signiﬁcant dif-
ference in the rate of MSIMI between men and
women. However, their study employed myocardial
perfusion imaging techniques (40), whereas our
study utilized real-time stress echocardiography as a
means of detecting MSIMI. Differences in our ﬁnd-
ings may speak to the underlying pathophysiological
basis of MSIMI. Perfusion abnormalities report on
obstructive coronary disease, whereas wall motion
abnormalities are generally considered an end
product of ischemia. A higher prevalence of MSIMI in
women with IHD in our study, as deﬁned by wall
Outcomes and CVD prognosis for women are worse, compared to men
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CENTRAL ILLUSTRATION Mental Stress, Sex, and Cardiovascular Disease
Effects of mental stress on psychophysiological domains, myocardial ischemia, and
outcomes in men and women.
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1676motion changes, may suggest that mechanisms such
as microvascular dysfunction, neurogenic stunning
of the myocardium, and other catecholamine-related
changes, similar to those postulated in Takotsubo or
stress-induced cardiomyopathy (a condition pre-
dominantly affecting postmenopausal women) may
be operational here (41). In the context of its known
poorer prognosis, the higher rate of MSIMI in women
observed in our study requires further investigation
because it may provide a potential explanation for
the “ischemic paradox” in women (42).
A prominent psychological response to mental
stress of increasing negative emotions and decreas-
ing positive emotions was documented for the entire
baseline REMIT cohort, though the magnitude of this
change was more pronounced in women than in
men. This observation supports the adequacy of the
mental stress tasks employed and is consistent with
previous data (43). In a study of college students,
socially stressful stimuli were associated with more
negative emotion in women than in men. Similar
to our ﬁndings, in that study, a greater elevation in
BP in men was observed (43). In another study
exploring the sex differences in cardiovascular
response and hypothalamic-pituitary-adrenal axis
response to stress, men had signiﬁcantly greater
cortisol and diastolic BP responses compared with
women (44). Among men, we found a trend towards
a correlation between BP and affect changes. Car-
diovascular reactivity to mental stress is known toplay a role in the development of hypertension, and
in younger adults, particularly men, this may pro-
vide a novel marker for hypertension and IHD risk
(45,46). Our ﬁndings validate previous work on sex-
speciﬁc cardiovascular and psychological responses
to stress. It is unclear whether the changes in BP in
response to mental stress are mediated through
affect changes. It is also not known whether these
differential responses to mental stress impact long-
term outcomes.
As a possible link between mental stress and
myocardial ischemia, the role of abnormal platelet
responses has been extensively studied. Previous
studies documented increased platelet aggregation
and secretion following mental stress tasks in healthy
individuals (47,48) and in patients with IHD (49). The
REMIT baseline population allowed for better sex-
speciﬁc characterization of platelet aggregation re-
sponses to mental stress. Our ﬁnding of a greater
increase in platelet aggregation (induced by collagen
10 mmol/l) in response to mental stress in women is
novel. It is important to note that although the
platelet aggregation to collagen in response to mental
stress was statistically different between the sexes,
similar trends were seen across other agonists, but
they did not reach statistical signiﬁcance. These
ﬁndings require further study in larger prospective
cohorts. Although there was a trend towards a cor-
relation between platelet reactivity and MSIMI
among women, platelet reactivity to collagen or
epinephrine did not alter the association of sex and
MSIMI. Hence, although these data are thought pro-
voking, we cannot conclude that changes in platelet
reactivity accounted for sex differences in the rate of
MSIMI. We have established, however, that there are
differences in platelet reactivity in response to
mental stress between men and women. This asso-
ciation is hypothesis generating for future studies
investigating poor cardiovascular outcomes in
women.
The implications of our ﬁndings are several-fold.
Poor cardiovascular outcomes in women may reﬂect
inherent sex-speciﬁc differences, several of which
were measured in our study. They also underscore
the inadequacy of available risk-prediction tools,
which currently fail to measure a full spectrum of
differential risk across mental stress–induced physi-
ological and psychological changes. We believe that
the sex disparity of psychophysiological responses to
mental/psychosocial stress needs to be recognized in
the cardiovascular risk assessment of patients,
tested, and subsequently validated along with stan-
dard risk-prediction algorithms. Furthermore, the
speciﬁc role of MSIMI in the prognosis of IHD,
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Sex-based dif-
ferences in response to mental stress are related to pathogenesis
and outcomes in cardiovascular disease and may be mediated, in
part, by changes in platelet reactivity.
COMPETENCY IN PATIENT CARE: Physiological differences
between men and women in response to mental or psychosocial
stress should be recognized during cardiovascular risk
assessment.
TRANSLATIONAL OUTLOOK: Increased platelet reactivity in
response to mental stress, even in patients receiving antiplatelet
medications, has potential implications for concurrent therapy
that should be investigated in future studies.
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1677particularly in women, needs to be further eluci-
dated, as do disease-modifying treatment targets
addressing MSIMI in men and women.
STUDY LIMITATIONS. Although the REMIT trial
enrolled a greater number of women than in past
heart–mind studies (8–10), the relatively small sam-
ple sizes and lack of platelet data on some patients
limit deﬁnitive conclusions about interrelationships
between sex, stress reactivity measures, and MSIMI.
A power estimate on the basis of the current study’s
sample size suggests that we had sufﬁcient power to
reliably detect medium-sized effects (i.e., Cohen’s
D ¼ 0.5 or greater). Assuming a balanced design of
equal numbers of males and females, we estimate
that we would need a sample size of 360 patients to
achieve 0.80 power to detect smaller effect sizes
(Cohen’s D ¼ 0.2 to 0.3). We believe that many of
the signiﬁcant differences between men and women
observed in this study highlight the robust nature
of these sex differences. Despite this limitation,
our ﬁndings are important and provide guidance
for future research designed to determine mecha-
nistic links between sex, MSIMI, and cardiovascular
outcomes.
In contrast to some prior heart–mind studies that
used myocardial perfusion imaging techniques to
describe MSIMI (8,10), we chose wall motion abnor-
malities and LVEF reductions on echocardiography as
a surrogate for ischemia. Myocardial ischemia
assessment by echocardiography is an established
and well-validated method (50). Echocardiography
allowed for real-time assessment of myocardial
ischemia and a comprehensive assessment of left
ventricular function, while avoiding unnecessary ra-
diation exposure.CONCLUSIONS
There are clear, measurable, and differential re-
sponses to mental stress in women and men across
multiple cardiovascular domains. Further studies
should determine the association of these sex differ-
ences in psychological, cardiovascular, and platelet
reactivity responses to mental stress and long-term
clinical outcomes.
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